` ADO (Anteotech Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

ADO
vs
S&P/ASX 300

Over the past 12 months, ADO has underperformed S&P/ASX 300, delivering a return of -66% compared to the S&P/ASX 300's 5% growth.

Stocks Performance
ADO vs S&P/ASX 300

Loading

Performance Gap
ADO vs S&P/ASX 300

Loading
ADO
S&P/ASX 300
Difference

Performance By Year
ADO vs S&P/ASX 300

Loading
ADO
S&P/ASX 300
Add Stock

Competitors Performance
Anteotech Ltd vs Peers

S&P/ASX 300
ADO
0KHE
TMO
DHR
207940
Add Stock

Anteotech Ltd
Glance View

Market Cap
20.3m AUD
Industry
Life Sciences Tools & Services

AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.

ADO Intrinsic Value
0.0016 AUD
Overvaluation 79%
Intrinsic Value
Price
Back to Top